SCHEMBL6415904

SCHEMBL6415904

NNc1nc2nonc2nc1NCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
KMT2A Q03164 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
BLM P54132 1/20 0.51
GAA P10253 2/20 0.45
APP P05067 5/20 0.44
RAD52 P43351 1/20 0.43
ALDH1A1 P00352 2/20 0.42
PKM P14618 1/20 0.42
UBE2N P61088 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RCE1 Q9Y256 1/20 0.42
CDK1 P06493 1/20 0.42
POLB P06746 1/20 0.41
PDE5A O76074 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6413439 0.98 LMNA (0.50) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL26034950 0.92 KMT2A (0.58) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL12858715 0.75 LMNA (0.50) LMNAKMT2AKDM4EMAPTMEN1
Hydrochloric Acid SCHEMBL6413522 0.74 MAPT (0.47) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6416975 0.72 MAPT (0.51) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6414665 0.72 DDX3X (0.53) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6414142 0.72 MAPT (0.43) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6416985 0.72 MAPT (0.51) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6414153 0.71 STAT6 (0.38) LMNAKMT2AKDM4EMAPTMEN1
SCHEMBL6414619 0.71 MEN1 (0.46) LMNAKMT2AKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed